Lv11
10 积分 2022-03-03 加入
The present and future of bispecific antibodies for cancer therapy
2小时前
已完结
The present and future of bispecific antibodies for cancer therapy
5小时前
已完结
Molecular and cellular insights into T cell exhaustion
8个月前
已完结
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis
9个月前
已完结
CD4 and CD8 T-cell positive selection increases the robustness of the CD22 CAR T-cell manufacturing process
11个月前
已完结
CAR T therapy beyond cancer: the evolution of a living drug
1年前
已完结
Automation Platform for CAR-T Manufacturing: The Benefits and the Clinical Outcomes
1年前
已关闭
Polo-like Kinase 1 as an emerging drug target: structure, function and therapeutic implications
1年前
已完结
Polymer particles for the intra-articular delivery of drugs to treat osteoarthritis
1年前
已完结
Global burden and trends of lung cancer incidence and mortality
1年前
已完结
皖公网安备34019202002308
